Trial Profile
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms testa-collo
- 31 May 2011 New trial record